Ranibizumab for the treatment of degenerative ocular conditions.

Triantafylla, Magdalini; Massa, Horace F; Dardabounis, Doukas; Gatzioufas, Zisis; Kozobolis, Vassilios; Ioannakis, Konstantinos; Perente, Irfan; Panos, Georgios D.

Triantafylla M; Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupolis, Greece.
Massa HF; Department of Ophthalmology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Switzerland.
Dardabounis D; Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupolis, Greece.
Gatzioufas Z; Department of Ophthalmology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Switzerland.
Kozobolis V; Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupolis, Greece.
Ioannakis K; Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupolis, Greece.
Perente I; Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupolis, Greece ; Beyoglou Eye Research and Teaching Hospital, Istanbul University, Istanbul, Turkey.
Panos GD; Department of Ophthalmology, University General Hospital of Alexandroupolis, School of Medicine, University of Thrace, Alexandroupolis, Greece ; Department of Ophthalmology, Geneva University Hospitals, Faculty of Medicine, University of Geneva, Switzerland.

Clin Ophthalmol ; 8: 1187-98, 2014.

Article en En | MEDLINE | ID: mdl-25028531